JenningsJESundgrenPCAttwoodJ. Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology2004; 46 (1): 15–21.
2.
PeterováVDostálCLinkováL. The distribution of MR lesions in neuropsychiatric lupus erythematosus and multiple sclerosis patients. Riv Neuroradiol2003; 16. 788–91.
3.
PodrazilováLPeterováVOlejárováM. Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematodes. Clin Exp Rheumat2008; 26 (4): 604–10.
4.
EmmerBJvan der GrondJSteup-BeekmanGM. Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med2006; 3 (12): e499.
5.
Multiple Sclerosis, Part I: Background and Conventional MRI NeuroimagClin N Am18 (2008) xiii.
6.
Multiple Sclerosis, Part II: Nonconventional MRI Techniques NeuroimagClin N Am19 (2009) xiii–xiv
7.
GeY.Multiple Sclerosis: The Role of MR ImagingAm. J. Neuroradiol., Jun 2006; 27: 1165–1176.
8.
SimonJHLiDTraboulseeA. Standardized MR Imaging Protocol for Multiple Sclerosis: Consortium of MS Centers Consensus GuidelinesAm J Neuroradiol, Feb 2006; 27: 455–461.
9.
IngleseM.. Multiple Sclerosis: New Insights and TrendsAm J Neuroradiol, May 2006; 27: 954–957.
10.
LövbladK-OAnzaloneNDörflerA. MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice. Am J Neuroradiol, Jun 2010; 31: 983–989.
11.
SimonJHScherzingerARaffU. Computerized method of lesion volume quantitation in multiple sclerosis: error of serial studies. Am J Neuroradiol1997; 18: 580–82.
12.
PanitchHGoodinDSFrancisG. Randomized, comparative study of interferon beta-1a treatment regimens in MS: the EVIDENCE Trial. Neurology2002; 59: 1496–506.
13.
KalkersNFAmezianeNBotJC. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch Neurol2002; 59: 1572–76.
14.
GrossmanRIGomoriJMRamerKN. Magnetization transfer: theory and clinical applications in neuroradiology. Radiographics1994; 14: 279–90.
15.
GuoACJewellsVLProvenzaleJM. Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging. Am J Neuroradiol2001; 22: 1893–900.
16.
GeYGrossmanRIBabbJS. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. Am J Neuroradiol2003; 24: 1935–40.
17.
PikeGBDe StefanoNNarayananS. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology2000; 215: 824–30.
18.
CatalaaIGrossmanRIKolsonDL. Multiple sclerosis: magnetization transfer histogram analysis of segmented normal-appearing white matter. Radiology2000; 216: 351–55.
19.
BarkhofFBruckWDe GrootCJ. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol2003; 60: 1073–81.
20.
van BuchemMAGrossmanRIArmstrongC. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology1998; 50: 1609–17.
21.
GeYGrossmanRIUdupaJK. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. Am J Neuroradiol2001; 22: 470–75.
22.
FilippiMIngleseM. Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis. J Neurol Sci2001; 186 (suppl 1): S37–43.
23.
FilippiMCercignaniMIngleseM. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology2001; 56: 304–11.
24.
CaramiaFPantanoPDi LeggeS. A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging2002; 20: 383–88.
25.
RovarisMGassABammerR. Diffusion MRI in multiple sclerosis. Neurology2005; 65: 1526–32.
26.
De StefanoNBartolozziMLGuidiL. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. J Neurol Sci2005; 233: 203–08.
27.
GonenOCatalaaIBabbJS. Total brain N-acetylaspartate: a new measure of disease load in MS. Neurology2000; 54: 15–19.
KangarluABourekasECRay-ChaudhuryA. Rammohan Cerebral Cortical Lesions in Multiple Sclerosis Detected by MR Imaging at 8 Tesla. Am. J. Neuroradiol., Feb 2007; 28: 262–266.
30.
NelsonFPoonawallaAHHouP. Narayana Improved Identification of Intracortical Lesions in Multiple Sclerosis with Phase-Sensitive Inversion Recovery in Combination with Fast Double Inversion Recovery MR ImagingAm J Neuroradiol, Oct 2007; 28: 1645–1649.
31.
FilippiMRoccaMA. MR Imaging of Gray Matte Involvement in Multiple Sclerosis: Implications for Understanding Disease Pathophysiology and Monitoring Treatment Efficacy. Am J Neuroradiol, Aug 2010; 31: 1171–1177.
32.
RhaJHSaverJL: The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke2007: 38: 967–73.
33.
SmithWsSungG. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke2008; 39: 1205–12.
34.
The Penumbra Pivotal Stroke Trial Investigators: The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke2009: 40: 2761–68.
35.
BrekenfeldCSchrothG. Mechanical thromboembolectomy for acute ischemic stroke: comparison of the catch thrombectomy device and the Merci Retriever in vivo. Stroke2008; 39: 1213–19.
36.
ArnoldMSchrothG. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke2002; 33: 1828–33.
37.
NedeltchevKBrekenfeldC. Stenting of the internal carotid artery in acute stroke: preliminary results of 25 patients. Radiology2005; 237: 1029–37.
38.
LevyEIMehtaR, Self-expanding stents for recanalization of acute cerebrovascular occlusions. Am J Neuroradiol2007; 28: 816–22.
39.
BrekenfeldCSchrothG. Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke2009; 40: 847–852.
40.
BrekenfeldCRemondaL. Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: as-self-expandable stentsment of 294 patients treated with urokinase. J Neurol Neurosurg Psychiatry2007; 78: 280–5.
41.
Mordasini. In-vivo evaluation of a dedicated combined flow restoration and mechanical thrombectomy device in a swine model of acute vessel occlusion. Am J Neuroradiol2010, accepted for publication.
SpelleLBoulinATainturierC: Neuroimaging features of spontaneous intracranial hypotension. Neuroradiology.2001: 43: 622–7
44.
FarbRIForghaniRLeeSK. The Venous Distension Sign: A Diagnostic Sign of Intracranial Hypotension at MR Imaging of the Brain. Am J Neuroradiol2007: 28: 1489–1493.
45.
MessoriASimonettiBFRegnicoloL. Spontaneous intracranial hypotension: the value of brain measurements in diagnosis by MRI. Neuroradiology2001: 43: 453–461.
46.
SavoiardoMMariniLFarinaL. Spontaneous intracranial hypotension with deep brain swelling. Brain2007: 130: 1884–1893.
47.
WangYFLirngJFFuhJL. Heavily T2-weighted MR myelography vs CT myelography in spontaneous intracranial hypotension. Neurology.2009 Dec 1; 73 (22): 1892–8.
48.
ZellerhoffMDeuerling-ZhengYStrotherCMMeasurement of cerebral blood volume using angiographic C-arm systems. Medical Imaging 2009: Biomedical Applications in Molecular, Structural, and Functional Imaging. Proc. SPIE; 7262: 72620H; doi 10.1117/12.812097
49.
WermerMJvan der SchaafIC. For the ASTRA Study Group. Brain2005; 128 (pt 10): 2421–29.
50.
SprengersMEvan RooijWJ. American Journal of Neuroradiol2009; 30: 303–307
51.
PurdyPDDuongRTWhiteCLIII. Percutaneous translumbar spinal cord compression injury in a dog model that uses angioplasty balloons: MR imaging and histopathologic findings. Am J Neuroradiol2003; 24: 177–184.
52.
FujimotoTGilesBPReplogleRE. Visualization of sacral nerve roots via percutaneous intraspinal navigation (PIN). Am J Neuroradiol2005; 26: 2420–2424.
53.
HorowitzMBRamzipoorKNairA. Experimental third ventriculostomy performed using endovascular surgical techniques and their adaptation to percutaneous intradural neuronavigation: Proof of concept cadaver study. Neurosurgery2003; 53: 387–392.
54.
PurdyPDReplogleREPrideGLJr. Percutaneous intraspinal navigation (PIN): Feasibility study of a new and minimally invasive approach to the spinal cord and brain in cadavers. Am J Neuroradiol2003; 24: 361–365.
55.
WarakaulleDRAvivRINiemannD. Embolisation of spinal dural arteriovenous fistulae with Onyx. Neuro - radiology45: 110–112, 2003.
56.
NoguieraRGGuilhermeDRabinovJD. Onyx Embolization for the treatment of spinal dural arteriovenous fistulae: Initial experience with long-term follow up: Technical case report. Neurosurgery2009; 64: E197–198.
57.
SchroederT. Imaging stem-cell-driven regeneration in mammals. Nature2008; 453: 345–351.
58.
PolitiLS. MR-based imaging of neural stem cells. Neuroradiology2007; 49: 523–534.
59.
PolitiLSBacigaluppiMBrambillaE. Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells2007; 25: 2583–2592.
60.
SchiffmannRvan der KnaapMS. An MRI based approach to the diagnosis of white matter disorders.Volume 72, Number 8, February 2009. 750–75
61.
BucknerRLAndrews-HannaJRSchacterDL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci.2008, 1124: 1–38.
MasseyVWallnerKE. Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys.1990 Feb; 18 (2): 395–8.
68.
LimDAChaSMayoMCChenMHKelesEVandenBergSBergerMS. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol.2007 Oct; 9 (4): 424–9.
69.
SantatrelloXGarbinGUkmarM. Dependance of fractionnal anisotropy in cervical spine from the number of diffusion gradients, repeated acquisition and voxel size. Mag. Res. Imaging (28); 70–76.
70.
VargasMIDelavelleJJlassiH. Clinical applications of diffusion tensor tractography pf the spinal cord. Neuroradiology2008 jan; 50 (1): 25–9.
71.
DucreuxDLepeintreJFFillardP. MR diffusion tensor imaging fiber tracking in 5 spinal cord astrocytomas. Am J Neuroradiol,2006 JAN 27: 214–16.
72.
DucreuxDFillardPFaconD. Diffusion tensor imaginging and fiber tracking in spinal cord lesions: current and future indications. Neuroim. Clinics of N. America2007.
73.
NowinskiWLThirunavuukarasuuAVolkau: The Cerefy Atlas of Cerebral Vasculature. Thieme, New York, 2009.
74.
NowinskiWL: The pyramidal brain atlas: from blocks to brain. ECR Today2010. 22.
75.
NowinskiWLChuaBCQianGY. An interactive 3D neuroanatomical atlas for teaching of clinical neurology. Journal of the Neurological Sciences, 19th World Congress of Neurology WCN 2009, Bangkok, Thailand, 24–30 October 2009, 285 (Suppl 1): S62.
76.
NowinskiWlChuaBCVolkauI. Simulation and assessment of cerebrovascular damage in deep brain stimulation using a stereotactic atlas of vasculature and structure derived from multiple 3T and 7T scans. Journal of Neurosurgery DOI: 10.3171/2010.2. JNS091528.
77.
NowinskiWLQianGBhanu PrakashKN: Analysis of ischemic stroke MR images by means of brain atlases of anatomy and blood supply territories. Academic Radiology2006; 13 (8): 1025–1034.
78.
Rosso. Radiology2009; 250: 184–192.
79.
Tourdias. Stroke2007; 38: 3165–3171.
80.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med, 2004, vol. 256, n° 3, 183–194.
81.
GuedjEBarbeauEJDidicM. Identification of subgroups in amnestic mild cognitive impairment. Neurology.2006 Jul 25; 67(2): 356–8.
82.
Balédent. ‘Cerebrospinal fluid dynamics and relation with blood flow: a magnetic resonance study with semiautomated cerebrospinal fluid segmentation’, Investigative radiology2001; 36 (7), 368–77.
Gupta. ‘Three-dimensional computational modeling of subjectspecific cerebrospinal fluid flow in the subarachnoid space’, Journal of biomechanical engineering, 2009; 131 (2), 021010.
85.
Soellinger. ‘3D cine displacement-encoded MRI of pulsatile brain motion’, Magnetic resonance in medicine, 2009; 61 (1), 153–62.
86.
KoeslingSKunkelPSchulT. Vascular anomalies, sutures and small canals of the temporal bone on axial CT. Eur J Radiol54: 335–343, 2005
87.
de BritoPMetaisJPLescanneE. Hypodensité tomodensitométrique péricochléaire: variante de la normale chez l'enfant. J Radiol87: 655–659, 2006
88.
HouraniRCareyJYousemDM. Dehiscence of the jugular bulb and vestibular aqueduct. Findings on 200 consecutive temporal bone computed tomography scans. J Comput Assist Tomogr29: 657–662, 2005
89.
OkesonJP. Functional anatomy. In: MainoG. Management of Temporomandibular Disorders and Occlusion. 5th ed.Bologna, Italy: Edizioni Martina; 2006: 1–127.
90.
EmshoffRBrandlmaierIBertramS. Relative odds of temporomandibular joint pain as a function of magnetic resonance imaging findings of internal derangement, osteoarthrosis, effusion, and bone marrow edema. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2003; 95: 437–45.
91.
PedullàEMeliGAGarufiA. Cascone Neuropathic pain in temporomandibular joint disorders: case-control analysis by MR imaging. Am J Neuroradiol. Aug; 30 (7): 1414–8. Epub 2009 Apr 8. PMID:19357384
BonettiMValdenassiL: Oxygenozone therapy in percutaneous treatment of discal hernias. In: Atti “Unconventional medicine at the beginning of the third millennium”, Pavia 4–6 Giugno, 1998. Ed. Cost. 1998.
PurdyPDFujimotoTReplogleRE. Percutaneous intraspinal navigation (PIN) for access to the subarachnoid space: Use of another natural conduit for neurosurgical procedures (published online). Neurosurg Focus2005; 19 (1): E11/1–5.
96.
HorowitzMBRamzipoorKNairA. Experimental third ventriculostomy performed using endovascular surgical techniques and their adaptation to percutaneous intradural neuronavigation: Proof of concept cadaver study. Neurosurgery2003; 53: 387–392.
97.
ShimojiKOguraMGamouS. A new approach for observing cerebral cisterns and ventricles via a percutaneous lumbosacral route by using fine, flexible fiberscopes. J Neurosurg2009; 110, 376–381.
98.
PurdyPDReplogleREPrideGLJr. Percutaneous intraspinal navigation (PIN): Feasibility study of a new and minimally invasive approach to the spinal cord and brain in cadavers. Am J Neuroradiol2003; 24: 361–365.
99.
MoriSCrainBJChackoVP. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol1999; 45: 265–269
KinoshitaMYamadaKHashimotoN. Fiber-tracking does not accurately estimate size of fiber bundle in pathological condition: initial neurosurgical experience using neuronavigation and subcortical white matter stimulation. Neuroimage.2005; 25: 424–429
102.
CoenenVAKringsTMayfrankL. Three-dimensional visualization of the pyramidal tract in a neuronavigation system during brain tumor surgery: first experiences and technical note. Neurosurgery.2001; 49: 86–93.
103.
HendlerTPiankaPSigalM. Delineating gray and white matter involvement in brain lesions: three-dimensional alignment of functional magnetic resonance and diffusion-tensor imaging. J Neurosurg.2003; 99: 1018–1027.
104.
HolodnyAISchwartzTHOllenschlegerM. Tumor involvement of the corticospinal tract: diffusion magnetic resonance tractography with intraoperative correlation. J Neurosurg.2001; 95: 1082.
105.
KunimatsuAAokiSMasutaniY. The optimal trackability threshold of fractional anisotropy for diffusion tensor tractography of the corticospinal tract. Magn Reson Med Sci.2004; 3: 11–17.
106.
KamadaKTodoTMasutaniY. Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation. J Neurosurg.2005; 102: 664–672.
107.
YamamotoAMikiYUrayamaS. Diffusion tensor fiber tractography of the optic radiation: analysis with 6-, 12-, 40-, and 81-directional motion-probing gradients, a preliminary study. Am J Neuroradiol.2007; 28: 92–96.
108.
YamamotoTYamadaKNishimuraT. Tractography to depict three layers of visual field trajectories to the calcarine gyri. Am J Ophthalmol.2005; 140: 781–785.
109.
TaokaTSakamotoMNakagawaH. Diffusion tensor tractography of the Meyer loop in cases of temporal lobe resection for temporal lobe epilepsy. Am J Neuroradiol.2008; 29: 1329–1334.
110.
YamadaK. Diffusion tensor tractography should be used with caution. Proc Natl Acad Sci U S A.2009; 106: E14.
111.
LynchD: “Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001”. Neurosurg Focus.2006 Apr 15; 20 (4): E1.
112.
Stupp: “Radiotheraphy plus concomitant adjuvant Temozolomide for GBM”N Engl J Med, 200510; 352: 987–996.
113.
Donahue: “influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.”Int J Radit Oncol Biol Phys199715; 38(5)911–914
114.
DavisFG: “Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991”. J Neurosurg.1998 Jan; 88 (1): 1–10.
115.
LacroixM. A multivariate analysis of 416 patients with GBM: prognosis, extent of resection, and survival”J Neurosurg, 2001, 95: 190–198.
116.
AlbertF. “Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its influence on Regrowth and Prognosis”Neurosurgery: January 1994; Volume 34, Issue 1, 45–61
117.
HessKR. “Extent of resection as a prognostic variable in the treatment of gliomas”. J Neuro-oncol42: 227–231, 1999 Journal.
118.
Ertl-WagnerB. Reliability of tumor volume estimation from MR images in patients with malignant glioma. Results from the American College of Radiology Imaging network (ACRIN) 6662 trial, Eur Radiol, 2009; 19: 500–609.
119.
StuppRMasonWPvan den BentMJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med2005; 352: 987–996.
120.
HegiMEDiserensACGorliaT. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med2005; 352: 997–1003.
121.
BrandesAAFranceschiETosoniA. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol2008; 26: 2192–2197.
122.
BrandesAAFranceschiETosoniA. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer2009; 115. 3512–3518.
123.
BrandesAAFiorentinoMV. The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer invest1996; 14. 551–559.
124.
WongETHessKRGleasonMJ. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol1999; 17. 2572–2578.
125.
VredenburghJJDesjardinsAHerndonJE. Bevacizumab, a monoclonal antibody to vascular endothelial growth factor (VEGF), and irinotecan for treatment of malignant gliomas. J Clin Oncol.2006; 24: 18S.
126.
VredenburghJJDesjardinsAHerndonJE2nd. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol2007; 25: 4722–4729.
127.
FriedmanHSPradosMDWenPY. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol2009; 27: 4733–4740.
128.
WenPYMacdonaldDRReardonDA. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol.
129.
PierotL.SpelleL.LeclercX.. Endovascular treatment of Unruptured Intracranial Aneurysms: Comparison of Safety of remodeling technique and standard treatment with coils. Radiology,2009, 251: 846–855.
130.
Malek. JAMA, 1999; 282: 2035–2042.
131.
Cunningham and Gotlieb Lab Inv, 2005, 85: 9–23.
132.
Stalder. MRM2008.
133.
Johnson. MRM2008. 60 (6): 1329–36.
134.
Johnson and Markl. MRM2010 (epub).
135.
Mistretta. MRM2006: 55 (1): 30–40.
136.
Oyre. JACC, 1998, 32: 1: 128–134.
137.
RammosSKMainaRLanzinoG. Developmental venous anomalies: current concepts and implications for management. Neurosurgery.65 (1): 20–9, 2009.
138.
ImSHHanMHKwonBJ. Venous-predominant parenchymal arteriovenous malformation: a rare subtype with a venous drainage pattern mimicking developmental venous anomaly. J Neurosurg.108 (6): 1142–7, 2008.
139.
AgazziSRegliLUskeA. Developmental venous anomaly with an arteriovenous shunt and a thrombotic complication. Case report. J Neurosurg.94 (3): 533–7, 2001.
140.
WalshMParmarHMukherjiSK. Developmental venous anomaly with symptomatic thrombosis of the draining vein. J Neurosurg.109 (6): 1119–22, 2008.
141.
FenziFRizzutoN. Ataxia and migraine-like headache in a girl with a cerebellar developmental venous anomaly. J Neurol Sci.273 (1–2): 127–9, 2008.
142.
RodeschG. Can the concept of benign developmental venous anomaly (the “So Called Venous Angioma”) be revisited. Presented at the IX WFITN Congress in Beijing, 2007.
143.
Alperin. J. Neurosurgery102: 46–52, 2005.
144.
TouzE. Reproducibility of High-Resolution MRI for the Identification and the Quantification of Carotid Atherosclerotic Plaque Components: Consequences for Prognosis Studies and Therapeutic Trials. Stroke2007; 38: 1812–1819.
145.
AdameIM. Automatic segmentation and plaque characterization in atherosclerotic carotid artery MR images. MAGMA2004; 16. 227–234.
146.
LiuF. Automated In Vivo Segmentation of Carotid Plaque MRI with Morphology-EnhancedProbability Maps Magnetic Resonance in Medicine2006; 55: 659–C668
147.
HofmanJMA. Quantification of Atherosclerotic Plaque Components Using In Vivo MRI and Supervised Classifiers. Magnetic Resonance in Medicine2006; 55: 790–C799
148.
World Health Organization.The world health report 2007: a safer future - global public health security in the 21st century. Geneva: WHO Press; 2007: 96.
149.
Agundes-PereyraWJCarvalhoGTde Miranda GoesA. Central nervous system paracoccidioidomycosis: analysis of 13 cases. Arq Neuropsiquiatr.2006; 64: 269–76.
150.
LucatoLTGuedesMSSatoJR. The Role of Conventional MR Imaging Sequences in the Evaluation of Neurocysticercosis: Impact on Characterization of the Scolex and Lesion Burden. Am J Neuroradiol.2007; 28: 1501–4.
151.
MarchioriPEAlexandrePLBrittoN. Late reactivation of Chagas' disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy. J Heart Lung Transplant.2007; 26: 1091–6.
152.
FerrariTC. Involvement of central nervous system in schistosomiasis. Mem Inst Oswaldo Cruz.2004; 99: 59–62.
153.
GultekinSHRosenfeldMRVoltzR. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain2000; 123: 1481–94.
154.
TüzünEDalmauJ. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist2007 Sep; 13 (5): 261–71. Review.
155.
HonnoratJ. Autoimmune limbic encephalitis: an expanding concept. Lancet Neurol Jan;9 (1): Epub 2009 Dec 2.
CrishSDSappingtonRMInmanDM. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. PNAS Proceedings of the National Academy of Sciences of the United States of America,2010: 107 (11): 5196–5201.
162.
GuptaNAngL-CNoël de TillyL. Br J Ophthalmol, 2006; 90, 6: 674–678.
163.
SlavinKVThulbornK: Direct visualization of the human STN with 3T MR imaging. Am J Neurorad.27: 80–4, 2006.
164.
MackAWolffR: Analyzing 3T MRI units for implementation in radiosurgery. J Neurosurg102 Suppl: 158–164, 2005.
165.
KitajimaMKorogiY. Human subthalamic nucleus: evaluation with high-resolution MR imaging at 3.0T. Neuroradiology2008; 50: 675–81.
166.
DormontDRicciardiKG. Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. Am J Neuroradiol2004; 25: 1516–23.
167.
BasserPJPajevichSPierpaoliC. In vivo fiber tractography using DT MRI data. Magn. Reson. Med.2000; 44: 625–632.
168.
MoriSBarkerPB. Diffusion magnetic resonance imaging: its principle and applications. Anat. Rec.1999; 257: 102–109.
169.
NorthKN. Neurofibromatosis 1 in childhood. Semin Pediatr Neurol1998; 5: 231–242.
170.
RosserTLVezinaGPackerRJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology.2005 8; 64 (3): 553–5.
171.
ReaDBrandsemaJFArmstrongD. Cerebral Arteriopathy in Children With Neurofibromatosis Type 1. Pediatrics.2009 Aug 24. [Epub ahead of print].
172.
SlavcISchullerECzechT. Kluwer Academic Publishers. Printed in the Netherlands Intrathecal mafosamide therapy for pediatric brain tumors with meningeal dissemination. Journal of Neuro-Oncology1998; 38: 213–218.
173.
SlavcIRodriguezIRMazurukK. Mutation analysis and loss of heterozygosity of PEDF in central nervous System, primitive neuroectodermal tumors. Wiley-Liss, Inc. Int. J. Cancer: 1997; 72: 277–282.
BaumannGSSneedPKWaraWM. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys1996; 36; 433–441.
176.
CombsSEThilmannCEdlerL. Efficacy of factionated stereotactic reirradiation in reccurent gliomas: long term results n 172 patients treated in a single institution. J Clin Oncol2005; 23: 8863–8869.
177.
RivaDGiorgiC. The cerebellum contributes to higher functions during development: evidence from a series of children surgically treated for posterior fossa tumours. Brain2000; 123: 1051–1061.
178.
WoodAG. Language cortex activation in normal children. Neurology2004; 65: 1035–1044.
179.
MarkisN. MRI-based surface-assisted parcellation of human cerebellar cortex: an anatomical specified method with estimated of reliability. NeuroImage2005; 25: 1146–1160.
180.
SchmahmannJDCaplanD. Cognition, emotion and the cerebellum. Brain2006; 129, 288–292.
181.
FischerUAncaD. Quality of Life in Stroke Survivors after Local Intra-Arterial ThrombolysisCerebrovasc Dis2008; 25: 438–44
182.
LövbladKOAltrichterS. Neuroimaging of cerebral ischemic strokeJ Neuroradiol.2008 Mar 7; 35(4): 197–209.
183.
MattleHPArnoldMGeorgiadisD. RW: Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery signStroke2008; 39 (2): 379–83.
184.
NedeltchevKSchweglerB. Outcome of stroke with mild or rapidly improving symptomsStroke2007; 38 (9): 2531–2535.
185.
AgyemanONedeltchevK. Time to Admission in Acute Ischemic Stroke and Transient Ischemic AttackStroke.2006; 37 (4): 963–966.
186.
IseneggerJNedeltchevK. Reasons to withhold intra-arterial thrombolysis in clinical practiceJ Neurol2006; 253: 1552–1556.
187.
NedeltchevKFischerU. Long-Term Effect of Intra-Arterial Thrombolysis in Stroke. Stroke2006; 37: 3002–3007.
188.
BrekenfeldCRemondaL. Endovascular neuroradiological treatment of acute ischemic stroke: techniques and results in 350 patientsNeurological Research, 2005, 27: 29–35.
189.
FischerUArnoldM. NIHSS Score and Arteriographic Findings in Acute Ischemic StrokeStroke2005; 36: 2121–2125.
190.
NedeltchevKBrekenfeldC. Internal carotid artery stent implantation in 25 patients with acute stroke: preliminary resultsRadiology2005; 237: 1029–1037.
191.
NedeltchevKArnoldM. Pre- and In-Hospital Delays From Stroke Onset to Intra-arterial ThrombolysisStroke2003; 34: 1230–1234.
192.
KunimatsuAAokiSMasutaniY. Three dimensional white matter tractography by diffusion tensor imaging in ischaemic stroke involving the corticospinal tract. Neuroradiology2003; 45: 532–535.
KonishiJYamadaKKizuO. MR tractography for the evaluation of the functional recovery from lenticulostriate infarct. Neurology.2005; 64: 108–113.
195.
NellesMGiesekeJFlackeS. Diffusion tensor pyramidal tractography in patients with anterior choroidal artery infarcts. Am J Neuroradiol.2008; 29: 488–93.
196.
KunimatsuAItohDNakataY. Utilization of diffusion tensor tractography in combination with spatial normalization to assess involvement of the corticospinal tract in capsular/pericapsular stroke: J Magn Reson Imaging.2007; 26: 1399–404.
197.
CataniMMesulamM. The arcuate fasciculus and the disconnection theme in language and aphasia: history and current state. Cortex.2008; 44: 953–61.
198.
YamadaKNagakaneTMizunoT. MR tractography depicting damage to the arcuate fasciculus in a patient with conduction aphasia. Neurology2007; 68, 789.
199.
HosomiANagakaneYYamadaK. Assessment of arcuate fasciculus with diffusion-tensor tractography may predict the prognosis of aphasia in patients with left middle cerebral artery infarcts. Neuroradiology.2009; 51: 549–555.
200.
YooSSParkHJSoulJS. In vivo visualization of white matter fiber tracts of preterm- and terminfant brains with diffusion tensor magnetic resonance imaging. Invest Radiol.2005; 40: 110–115.
201.
HoonAHJrLawrieWTJrMelhemER. Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology.2002; 59: 752–756.
202.
MurakamiAMorimotoMYamadaK. Fiber-tracking techniques can predict the degree of neurologic impairment for periventricular leukomalacia. Pediatrics2008; 122: 500–506.
203.
ChaloupkaJHuddleD: Classification of vascular malformation of the central nervous system. Neuroimaging Clinics of North America8: 2-295–321, 1998.
204.
BarrRMDillonWPWilsonCB: Slow-flow vascular malformation of the pons: Capillary telangiectasias?AM J Neuroradiol17. 71–78, 1996.
205.
AwadIARobinsonJRMohantyS. Mixed Vascular malformations of the brain: Clinical and pathogenic conciderations. Neurosurgery33: 179–188, 1993.
FarbRIAgidRWillinskyRA. Cranial Dural Arteriovenous Fistula: Diagnosis and Classification with Time-Resolved MR Angiography at 3T. Am. J. Neuroradiol., Sep 2009; 30: 1546–1551.
208.
BrodmannKorbinian, Vergleichende Lokalisationslehre der Grosshirnrinde in Ihren Prinzipien dargestellt auf Grund des Zellenbaues, Johann Ambrosius Barth Verlag, Leipzig, 1909 (English translation by Garey, 1994).
209.
KettelerDKastrauFVohnR. The subcortical role of language processing. High level linguistic features such as ambiguity resolution and the human brain; an fMRI study. Neuroimage,2008; 39.4: 2002–09.
210.
WhelessJWSimosPGButlerIJ. Language dysfunction in epileptic conditions. Semin Pediatr Neurol.2002 Sep; 9 (3): 218–28. Review.
211.
BiswalBYetkinFZHaughtonVM. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med.1995 Oct; 34 (4): 537–41.
212.
GreiciusMDSupekarKMenonV. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex.2009 Jan; 19 (1): 72–8. Tecnological and semantic language task in healthy subjects. Hum Brain Mapp.2004 Nov; 23 (3): 140–55.
213.
HermannBPGoldJPusakulichR. Wechsler adult intelligence scale-revised in the evaluation of anterior temporal lobectomy candidates. Epilepsia.1995 May; 36 (5): 480–7.
StaudtMLidzbaKGroddW. Right-hemispheric organization of language following early leftside brain lesiona: functional MRI topography. NeuroImage2002; 16: 954–967.
218.
SaurDLangeRBaumaertnerA. Dynamics of language reorganization after stoke. Brain2006; 129: 1371–1384.
219.
LVoets NEAdcock JFlitney DE. Distinct right frontal lobe activation in language processing following left hemisphere injury. Brain2006; 129: 754–766.
220.
BookheimerS. Functional MRI of language: new approaches to understanding the cortical organization of semantic processing. Ann Rev of Neurosci2002; 25: 151–188.
221.
GarelC (ed). MRI of the fetal brain. Berlin, Springer-Verlag, 2004.
222.
GriffithsPD (eds). Atlas of fetal and post natal brain MR. Philadelphia, Mosby Elsevier, 2010.
223.
MoesPSchilmoellerKSchilmoellerG. Physical, motor, sensory and developmental features associated with agenesis of the corpus callosum. Child Care Health Dev2009; 35: 656–672.
224.
Tovar-MollFMollJde Oliveira-SouzaR. Neuroplasticity in human callosal dysgenesis: a diffusion tensor imaging study. Cereb Cortex2007; 17. 531–541.
225.
WahlMStromingerZJeremyRJ. Variability of homotopic and heterotopic callosal connectivity in partial agenesis of the corpus callosum: a 3T diffusion tensor imaging and Q-ball tractography study. Am J Neuroradiol2009: 30: 282–289.
226.
LarssonH. JMRI2008; 27: 754 (2008)
227.
LarssonH. MRM2009; 62: 1270.
228.
SourbronS. MRM2009; 62: 205.
229.
HuLS. Am J Neuroradiol2009; 30: 552
230.
BoxermanJL. Am J Neuroradiol2006; 27: 859.
231.
PatlakCS. JCBFM1985; 5: 584.
232.
PedersenH. Proc. of ISMRM2009: 124.
233.
KornienkoV.ProninI. Diagnostic Neuroradiology, “N.M. Andreev”, Moscow, Vol. II, Suppl. P. 2009; 425–462.
234.
JainR. First-pass Perfusion Computed Tomography: Initial Experience in Differentiating Recurrent Brain Tumors from Radiation Effects and Radiation Necrosis. Neurosurgery2007; 61, 778–787.